Back to Results
First PageMeta Content
Dual-energy X-ray absorptiometry / Osteoporosis / Bone density / Aromatase inhibitor / Tamoxifen / Breast cancer / Aromatase / Bisphosphonate / Vitamin D / Medicine / Health / Radiology


Microsoft Word - 1313_BMDusingDXAAromataseInhibitor_AttA_FinalAssessmentReport -accessible.docx
Add to Reading List

Document Date: 2015-04-15 22:13:39

Open Document

File Size: 877,59 KB

Share Result on Facebook

City

Canberra / /

Company

Hologic / GE / /

Country

Australia / /

Currency

USD / /

/

Facility

Griffith University / /

Holiday

Commonwealth Day / Commonwealth Day of Australia / /

IndustryTerm

clinical decision algorithm / treatment for early breast cancer / fracture risk assessment tools / clinical algorithm / health technology reports / age / clinical risk fracture tools / breast cancer patients receiving aromatase inhibitor treatment Internet / Anti-resorptive combination products / search results / energy / /

MedicalCondition

breast cancer AI / osteopenia / arthralgia / hot flushes / early breast cancer / fever / pain / premature menopause / fatigue / skeletal metastases / early stage breast cancer / osteoporosis / breast cancer / /

MedicalTreatment

chemotherapy / Radiation / /

Organization

World Health Organization / Australian and New Zealand Bone Mineral Society / Griffith University / Australian Government / Department of Health / Medical Services Advisory Committee / Health Expert Standing Panel / Medicare / /

Position

Governor / Minister / Executive / physician / consultant physician / specialist physician / General / Marshall / /

Product

Vitamin D / /

Technology

Radiation / Diagnostic Imaging / X-ray / artificial intelligence / chemotherapy / agreed final Protocol / agreed Protocol / clinical decision algorithm / /

URL

http /

SocialTag